Business
Press Release Mar 08 2023
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 08, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 08, 2023, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg.\". View Attachment","length":425,"tagName":"div"}]